B Slocombe

1.1k total citations
31 papers, 870 citations indexed

About

B Slocombe is a scholar working on Molecular Medicine, Pharmacology and Molecular Biology. According to data from OpenAlex, B Slocombe has authored 31 papers receiving a total of 870 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Medicine, 15 papers in Pharmacology and 8 papers in Molecular Biology. Recurrent topics in B Slocombe's work include Antibiotic Resistance in Bacteria (16 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and Essential Oils and Antimicrobial Activity (5 papers). B Slocombe is often cited by papers focused on Antibiotic Resistance in Bacteria (16 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and Essential Oils and Antimicrobial Activity (5 papers). B Slocombe collaborates with scholars based in United Kingdom, United States and Australia. B Slocombe's co-authors include R. Sutherland, Caroline Perry, James William Gilbart, Karen E. Griffin, Ron Boon, Alan R. White, MICHAEL J. BASKER, Anthony R. White, Stephen W. Elson and Robert Edmondson and has published in prestigious journals such as Nature, The American Journal of Medicine and Antimicrobial Agents and Chemotherapy.

In The Last Decade

B Slocombe

31 papers receiving 773 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B Slocombe United Kingdom 13 322 314 264 252 198 31 870
Christine Warren United Kingdom 19 269 0.8× 140 0.4× 226 0.9× 269 1.1× 191 1.0× 36 927
Sachiko Gotô Japan 20 411 1.3× 162 0.5× 247 0.9× 346 1.4× 121 0.6× 92 1.1k
Sidney Cohen United States 18 459 1.4× 580 1.8× 213 0.8× 165 0.7× 106 0.5× 41 959
C.-J. Soussy France 15 146 0.5× 223 0.7× 272 1.0× 162 0.6× 116 0.6× 29 664
Yoshikuni Onodera Japan 16 356 1.1× 311 1.0× 439 1.7× 219 0.9× 211 1.1× 20 833
W. TOSCH Switzerland 10 274 0.9× 117 0.4× 237 0.9× 165 0.7× 100 0.5× 17 669
Jeffrey R. Aeschlimann United States 14 235 0.7× 420 1.3× 299 1.1× 214 0.8× 169 0.9× 19 750
K. Coleman United States 8 414 1.3× 187 0.6× 305 1.2× 145 0.6× 75 0.4× 8 839
A Buré France 14 140 0.4× 270 0.9× 433 1.6× 249 1.0× 312 1.6× 45 884
B Kolek United States 13 151 0.5× 173 0.6× 294 1.1× 307 1.2× 206 1.0× 16 637

Countries citing papers authored by B Slocombe

Since Specialization
Citations

This map shows the geographic impact of B Slocombe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Slocombe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Slocombe more than expected).

Fields of papers citing papers by B Slocombe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Slocombe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Slocombe. The network helps show where B Slocombe may publish in the future.

Co-authorship network of co-authors of B Slocombe

This figure shows the co-authorship network connecting the top 25 collaborators of B Slocombe. A scholar is included among the top collaborators of B Slocombe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Slocombe. B Slocombe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, G M, et al.. (1998). Activity of Amoxicillin-Clavulanate against Penicillin-Resistant Streptococcus pneumoniae in an Experimental Respiratory Infection Model in Rats. Antimicrobial Agents and Chemotherapy. 42(4). 813–817. 12 indexed citations
2.
Slocombe, B. (1994). The Future of Antibacterial Chemotherapy. Zentralblatt für Bakteriologie. 281(3). 346–352. 3 indexed citations
3.
Slocombe, B & Caroline Perry. (1991). The antimicrobial activity of mupirocin—an update on resistance. Journal of Hospital Infection. 19. 19–25. 45 indexed citations
4.
Cooper, Christine E., Anthony R. White, & B Slocombe. (1991). Activity of human extravascular temocillin concentrations simulated in an in-vitro kinetic model against β-lactamase producing Gram-negative bacilli. Journal of Antimicrobial Chemotherapy. 27(1). 105–115. 3 indexed citations
5.
6.
Cooper, Christine E., B Slocombe, & Anthony R. White. (1990). Effect of low concentrations of clavulanic acid on the in-vitro activity of amoxycillin against β-lactamase-producing Branhamella catarrhalis and Haemophilus influenzae. Journal of Antimicrobial Chemotherapy. 26(3). 371–380. 30 indexed citations
7.
Slocombe, B, et al.. (1989). Bactericidal effects of amoxycillin/clavulanic acid against Legionella pneumophila. Journal of Antimicrobial Chemotherapy. 23(1). 43–51. 13 indexed citations
8.
Wilkinson, M. J., et al.. (1989). Bactericidal effects of amoxycillin/clavulanic acid against intracellular Legionella pneumophila in tissue culture studies. Journal of Antimicrobial Chemotherapy. 23(4). 547–556. 18 indexed citations
9.
Slocombe, B, et al.. (1987). Effect of ceftriaxone on bacterial killing by human neutrophils in vitro.. PubMed. 6(2 Suppl). 234–40. 1 indexed citations
10.
White, Anthony R., Christine E. Cooper, Karen E. Griffin, & B Slocombe. (1986). Antibacterial activity of resolved temocillin epimers. Journal of Antimicrobial Chemotherapy. 18(3). 335–343. 1 indexed citations
11.
BASKER, MICHAEL J., D. J. Merrikin, Roger J. Ponsford, B Slocombe, & Tim Tasker. (1986). BRL 20330, an oral prodrug of temocillin: bioavailability studies in man. Journal of Antimicrobial Chemotherapy. 18(3). 399–405. 3 indexed citations
12.
Slocombe, B. (1986). Inhibition of ??-Lactamases in Branhamella catarrhalis. Drugs. 31(Supplement 3). 79–81. 2 indexed citations
13.
Harrington, Frank P., Peter H. Milner, Roger J. Ponsford, et al.. (1986). Structure-activity relationships of some 6.ALPHA.-formamido penicillins.. The Journal of Antibiotics. 39(10). 1498–1501. 9 indexed citations
14.
Mellows, G., et al.. (1985). Human pharmacokinetics of temocillin (BRL 17421) side chain epimers. Journal of Antimicrobial Chemotherapy. 15(3). 327–336. 4 indexed citations
15.
Sutherland, Robert L., et al.. (1985). Antibacterial activity of ticarcillin in the presence of clavulanate potassium. The American Journal of Medicine. 79(5). 13–24. 26 indexed citations
16.
Slocombe, B, Christine E. Cooper, Karen E. Griffin, & Anthony R. White. (1985). Temocillin. Drugs. 29(Supplement 5). 49–56. 3 indexed citations
17.
Slocombe, B, MICHAEL J. BASKER, P. H. BENTLEY, et al.. (1981). BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humans. Antimicrobial Agents and Chemotherapy. 20(1). 38–46. 101 indexed citations
18.
Thin, R N, et al.. (1977). A double trial of amoxycillin in the treatment of gonorrhoea.. Sexually Transmitted Infections. 53(2). 118–120. 4 indexed citations
19.
Slocombe, B & R. Sutherland. (1969). Sensitivity of Gram-negative bacilli to ampicillin after six years' clinical use. Journal of Clinical Pathology. 22(6). 644–648. 13 indexed citations
20.
Slocombe, B & R. Sutherland. (1969). Beta-lactamase activity and resistance to ampicillin, carbenicillin, and cephaloridine of Klebsiella, Enterobacter, and Citrobacter.. PubMed. 9. 78–85. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine Warren Breakdown of academic impact, for papers by Sachiko Gotô Breakdown of academic impact, for papers by Sidney Cohen Breakdown of academic impact, for papers by C.-J. Soussy Breakdown of academic impact, for papers by Yoshikuni Onodera Breakdown of academic impact, for papers by W. TOSCH Breakdown of academic impact, for papers by Jeffrey R. Aeschlimann Breakdown of academic impact, for papers by K. Coleman Breakdown of academic impact, for papers by A Buré Breakdown of academic impact, for papers by B Kolek
Rankless by CCL
2026